NEW YORK, Sept. 5, 2012 /PRNewswire/ — Reportlinker.com announces that a new market research report is available in its catalogue: Global Medical Laboratories Industry http://www.reportlinker.com/p0960414/Global-Medical-Laboratories-Industry.html#ut…
Bayer challenges compulsory licence issued by India – Channel News Asia
Wall Street Journal (India)Bayer challenges compulsory licence issued by IndiaChannel News AsiaOver 25,000 patients suffering from liver and kidney cancer die every year in India. Doctors said at least half of them could be saved with timely diagnosis …
Rigel Initiates Phase 2 Clinical Studies with R343 for Asthma and R333 for … – The Herald | HeraldOnline.com
Rigel Initiates Phase 2 Clinical Studies with R343 for Asthma and R333 for …The Herald | HeraldOnline.com… R343, an inhaled SYK inhibitor for asthma and R333, a topical JAK/SYK inhibitor for discoid lupus – both of which have commenced Phase 2 cl…
Pluristem stem cells save 3rd bone marrow disease patient – Globes
Pluristem stem cells save 3rd bone marrow disease patientGlobesDue to the patient's life threatening condition, 144 days after the bone marrow transplantation, PLX cells were twice injected intramuscularly, one week apart. No local or systemic side…
Pluristem stem cells save 3rd bone marrow disease patient
The 45-year old man suffered from bone marrow failure after undergoing chemotherapy and a bone-marrow transplant, due to leukemia.
India steps up TB fight as fears of drug-resistant strains mount – Washington Post
India steps up TB fight as fears of drug-resistant strains mountWashington PostBy Simon Denyer, The Washington Post. MUMBAI — The discovery of an almost untreatable form of tuberculosis in India has set off alarm bells around the world and helped spu…
Pharmacyclics Reports Fourth Quarter And Full Year Fiscal 2012 Financial … – Daily Markets
Pharmacyclics Reports Fourth Quarter And Full Year Fiscal 2012 Financial …Daily MarketsPhase III study of ibrutinib in combination with bendamustine and rituximab in patients with relapsed/refractory CLL/SLL: A randomized, multi-center Phase III, dou…
Pharmacyclics Reports Fourth Quarter and Full Year Fiscal 2012 Financial … – The Herald | HeraldOnline.com
Pharmacyclics Reports Fourth Quarter and Full Year Fiscal 2012 Financial …The Herald | HeraldOnline.comPhase III study of ibrutinib in combination with bendamustine and rituximab in patients with relapsed/refractory CLL/SLL: A randomized, multi-cente…
AlloCure commences AC607 Phase 2 clinical trial for acute kidney injury – News-Medical.net
AlloCure commences AC607 Phase 2 clinical trial for acute kidney injuryNews-Medical.netAlloCure, Inc. today announced that it has initiated a phase 2 clinical trial of AC607, the company's mesenchymal stem cell therapy, as a potential treatment for…
Not all obese people are unhealthy – Times of India
FirstpostNot all obese people are unhealthyTimes of India… 30-50 per cent for the metabolically healthy but obese people, and there were no significant differences observed between them and the metabolically healthy, normal weight participants. The s…